Not Rated
|
Fund Size
(0.54% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 10-Nov-25 | 10060.40 | 0.60% | - | 1.30% | 209/242 |
| 1 Month | 17-Oct-25 | 9963.70 | -0.36% | - | 1.15% | 193/235 |
| 3 Month | 14-Aug-25 | 10011.60 | 0.12% | - | 4.98% | 227/235 |
| 6 Month | 16-May-25 | 10561.70 | 5.62% | - | 6.28% | 119/225 |
| YTD | 01-Jan-25 | 9809.60 | -1.90% | - | 4.93% | 171/211 |
| 1 Year | 14-Nov-24 | 10544.20 | 5.44% | 5.40% | 7.67% | 126/198 |
| 2 Year | 17-Nov-23 | 14527.50 | 45.27% | 20.50% | 18.31% | 51/154 |
| 3 Year | 17-Nov-22 | 17781.00 | 77.81% | 21.13% | 19.03% | 43/128 |
| 5 Year | 17-Nov-20 | 22472.00 | 124.72% | 17.57% | 20.73% | 71/104 |
| Since Inception | 02-Jul-18 | 38944.00 | 289.44% | 20.22% | 12.97% | 36/216 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12487.93 | 4.07 % | 7.57 % |
| 2 Year | 17-Nov-23 | 24000 | 27115.3 | 12.98 % | 12.18 % |
| 3 Year | 17-Nov-22 | 36000 | 48049.7 | 33.47 % | 19.64 % |
| 5 Year | 17-Nov-20 | 60000 | 92300.83 | 53.83 % | 17.23 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3388.9 | 12.01% | 0.44% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 2504.4 | 8.88% | 1.12% | 8.88% (Oct 2025) | 5.35% (Nov 2024) | 3.72 L | -5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1808.1 | 6.41% | -0.56% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.56 L | -0.30 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1751.6 | 6.21% | -0.02% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.28 L | -4.00 k |
| Cipla Ltd. | Pharmaceuticals | 1528.4 | 5.42% | -0.61% | 7.6% (Feb 2025) | 5.42% (Oct 2025) | 10.18 L | -0.90 L |
| Lupin Ltd. | Pharmaceuticals | 1431.7 | 5.07% | 0.03% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1220.6 | 4.33% | 0.14% | 4.33% (Oct 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1153.1 | 4.09% | -0.24% | 7.62% (Dec 2024) | 4.09% (Oct 2025) | 10.12 L | -0.90 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1133.5 | 4.02% | -0.18% | 6.38% (Dec 2024) | 4.02% (Oct 2025) | 9.46 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1064 | 3.77% | 0.03% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.78% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 2.63 | 14.49 | 44.68 | 43.35 | 35.14 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 0.96 | 2.61 | 14.67 | 29.19 | 15.26 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 4.45 | 9.70 | 18.68 | 25.31 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 1.68 | 8.32 | 17.37 | 23.55 | 12.64 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.77 | 10.08 | 18.60 | 23.12 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.94 | 7.33 | 11.43 | 22.25 | 19.79 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.67 | 9.12 | 8.59 | 21.83 | 13.64 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | 2.20 | 3.48 | 12.80 | 21.73 | 16.54 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.47 | 8.13 | 7.34 | 21.59 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.16 | 7.83 | 9.06 | 20.57 | 17.54 |
Out of 102 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 6 is/are ranked 4 * , 5 is/are ranked 3 * , 4 is/are ranked 2 * , and 85 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund - Growth | 3 | 42980.74 | 2.18 | 7.25 | 8.41 | 11.89 | 17.50 |
| Mirae Asset Large Cap Fund - Regular - Growth | 3 | 41087.55 | 1.68 | 5.43 | 5.58 | 10.86 | 13.15 |
| Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth | 4 | 27069.09 | 1.89 | 6.45 | 7.64 | 12.53 | 17.44 |
| Mirae Asset Midcap Fund - Regular Plan - Growth | 3 | 18112.14 | 2.92 | 8.18 | 12.92 | 14.00 | 21.08 |
| Mirae Asset Liquid Fund - Growth | 4 | 14283.52 | 0.49 | 1.43 | 2.98 | 6.62 | 6.97 |
| Mirae Asset Aggressive Hybrid Fund - Growth | 3 | 9424.67 | 1.34 | 4.33 | 5.17 | 10.27 | 13.65 |
| Mirae Asset Focused Fund - Growth | 2 | 7979.98 | 0.06 | 3.36 | 3.56 | 6.15 | 11.53 |
| Mirae Asset Great Consumer Fund - Growth | NA | 4769.48 | -1.21 | 4.05 | 6.59 | 8.12 | 17.67 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.30 | 5.78 | 4.90 | 11.76 | 13.57 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.30 | 5.78 | 4.90 | 11.76 | 13.57 |